MedTrace Logo

Weekly Antepartum Testing in Women With BMI 30-40 and Neonatal Outcomes

NCT04180566 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2021-07-07

No results posted yet for this study

Summary

The purpose of study is to evaluate whether weekly antenatal testing in pregnant women with body mass index (BMI) 30-40 in the third trimester is associated with earlier delivery when compared to growth ultrasounds every 4 weeks. The investigators will also assess the differences in maternal and neonatal outcomes between the groups.

Conditions

  • Obesity Complicating Childbirth

Interventions

OTHER

Ultrasound Examination

Includes a regular growth ultrasound examination.

OTHER

Antenatal Testing (biophysical profile)

Includes weekly ultrasounds with a biophysical profile, which measures fetal tone, fetal movements, fetal breathing and amount of amniotic fluid (water around baby).

Sponsors & Collaborators

Principal Investigators

  • Cynthia Gyamfi-Bannerman, MD, MSc · Professor of Obstetrics/Gyn, Columbia University

  • Maria Andrikopoulou, MD, PhD · Postdoctoral Clinical Fellow in the Department of Obstetrics

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-04
Primary Completion
2021-03-10
Completion
2021-03-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04180566 on ClinicalTrials.gov